Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities
开发以证据为基础、经济有效的P4癌症药物，以推动预防、治疗、患者护理方面的创新，并减少医疗保健不平等现象。
期刊:Molecular Oncology
影响因子:4.5
doi:10.1002/1878-0261.70179
Ringborg, Ulrik; von Braun, Joachim; Celis, Julio; Berns, Anton; Baumann, Michael; Albreht, Tit; Abou-Zeid, Nancy; Bagnato, Vanderlei; Brandts, Christian; Chen, Chien-Jen; di Pietro, Massimiliano; Dosanjh, Manjit; Dubois, Thomas; Eggermont, Alexander; Eggert, Angelika; Ernberg, Ingemar; Faithfull, Sara; Förner, Johannes; Fröhling, Stefan; Heitor, Manuel; Hood, Leroy; Jiang, Wei; Jönsson, Bengt; Kannan, Ravi; Leptin, Maria; Li, Su; Lindgren, Peter; Lowy, Douglas; Ma, Jun; Markham, Alex; Nagy, Péter; Oberst, Simon; Parker, M Iqbal; Rodin, Danielle; Ryan, Kevin; Schüz, Joachim; Sullivan, Richard; Tabernero, Josep; Turkson, Peter; Várhelyi, Oliver; Varmus, Harold; Wang, Chijie; Weiderpass, Elisabete; Wilking, Nils
